Location: Home
  • search
  • go
  • Relate News
  • 10/2/2024Publication Announcement on the Inclusion of Marstacimab as Pilot Proj...
  • 10/1/2024HUTCHMED Announces Japan Approval for FRUZAQLA (fruquintinib) Received...
  • 10/1/2024InventisBio Prevails in Trade Secret Misappropriation Lawsuit Filed by...
  • 10/1/2024Alphamab and CSPC Enter a Licensing Deal on Anti-HER2 BsADC JSKN003 in...
  • 10/1/2024Akeso's Ebronucimab (PCSK9) Approved for Hypercholesterolemia in China
  • 10/1/2024Biotheus to Initiate Phase 3 Trial of BsAb PM8002 for SCLC
  • 10/1/2024Regeneron and Sanofi Announced Chinese Approval of Dupixent as the Fir...
  • 10/1/2024MediLink Registers Phase 3 Trial of Its B7H3 ADC YL201
  • 10/1/2024Lepu Biopharma Files NDA for Lead Product EGFR ADC MRG003
  • 10/1/2024Akeso's Cadonilimab Receives Second Indication Approval from NMPA
  • 10/1/2024Haleon Plans to Raise Stake in Chinese JV to 88%
  • 10/1/2024AFT in China License Deal with Xizang Weixinkang Pharma for Maxigesic ...
  • 10/1/2024China's Pharmaceutical Antimonopoly Guidelines Pose New Challenges for...
  • 9/27/2024Recent Executive Moves
  • 9/27/2024TJ Biopharma Secures €213M Deal with Sanofi for Greater China Rights ...
  • 9/27/2024Junshi Announces EC Approval of Toripalimab
  • 9/23/2024Is Biotech the Next Battleground in US-China Decoupling? (SCMP)
  • 9/20/2024Another Twist in the Biosecure Drama Leaves Bill's Fate Uncertain
  • 9/20/2024Why 'Big Pharma' Will be the Next China Trade War Battleground (Invest...
  • 9/20/2024Ocumension Therapeutics's ZERVIATE Approved in China
  • 9/20/2024NMPA Deputy Commissioner Meets with Danish Delegation
  • 9/20/2024Recent Executive Moves
  • 9/19/2024Kite Sells Stake in Fosun JV, Giving Chinese Partner Full Control of C...
  • 9/19/2024China's Implementation of Patent Term Adjustment (SM)
  • 9/17/2024NHC's Annual Statistical Report on China Healthcare Sector Development...
  • 9/17/2024Biopharma Prepares to Pivot from China as Biosecure Act Advances (Phar...
  • 9/17/2024NHSA Announces Conclusion of Expert Evaluation for 2024 DRDL Inclusion...
  • 9/13/2024NHSA and MOF Jointly Issue Reform Policies Relatinng to Direct Settlem...
  • 9/13/2024Organon Enters into China Licensing Deal for Fertility Asset with Bao ...
  • 9/13/2024IQVIA: Chinese Hospital Drug Market Down 0.2% in MAT Q2/2024
  • Page:18/354 Total number of articles:10618: [First][<<] [16] [17] [18] [19] [20] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group